Lincoln Pharmaceuticals Ltd. Financials

15:51 May 30

Lincoln Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
542.05
-0.20 (-0.04%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Lincoln Pharmaceuticals Ltd. Financials

Lincoln Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
542.05
-0.20 (-0.04%)
15:51 May 30
Quality
image/svg+xml

55/100
High Financial Strength

Valuation
image/svg+xml

58/100
Affordable Valuation

Technical

31/100
Technically Bearish

Strength

6

Weakness

3

Opportunity

0

Threats

0

12.25 %

ROE %

10.33 %

ROA %

41.11

EPS

335.34

BVPS

13.21 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
424.19 472.12 510.31 580.55 623.23
Operating Expenses +
337.01 376.64 421.1 480.65 521.74
Raw Material
193.74 232.15 245.64 284.03 282.48
Increase Decrease in Cost
3.99 -13.57 -4.24 -5.7 8.84
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
60.74 70.47 93.16 102.9 112.45
Miscellaneous Expenses
219.16 234.93 223.82 265.24 255.05
Operating Profit
87.18 95.48 89.21 99.9 101.49
Other Income
5.66 10 22.47 34.42 22.48
Depreciation
7.56 8.09 9.17 10.62 12.9
Interest
1.56 1.45 2.03 1.46 1.88
Profit before tax and exceptio..
83.72 95.94 100.48 122.24 109.19
Exceptional Items
0 0 0 0 0
PBT
83.72 95.94 100.48 122.24 109.19
Provision for Taxation
21.47 26.58 27.58 28.94 26.84
Net Profit
62.25 69.36 72.9 93.3 82.35
NET Profit after MI
62.22 69.36 72.9 93.3 82.35
EPS
31.11 34.63 36.4 46.58 41.11
Operating Profit Margin (%)
20.55 20.22 17.48 17.21 16.28
Net Profit Margin (%)
14.67 14.69 14.29 16.07 13.21

Lincoln Pharmaceuticals Ltd. Shareholding

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 49.80 49.80 49.80 49.80 49.50
FII 5.00 5.20 5.20 4.00 3.90
MF 0.00 0.00 0.00 0.00 0.00
Public 45.20 45.10 45.00 46.20 46.50
Others 0.00 0.00 0.00 0.00 0.00
Others 0.00 -0.10 0.00 0.00 0.10
Shareholder Shares Holding %
Download Our App On: